Palatin Technologies (PTN) Announces Third Quarter Fiscal Year 2013 Results and Update on Development of Bremelanotide for Female Sexual Dysfunction
5/14/2013 7:08:12 AM
More...
|
Palatin Technologies (PTN) to Report Fiscal Year 2013 Third Quarter Results; Teleconference and Webcast to be Held on May 14, 2013
5/8/2013 7:15:32 AM
More...
|
Palatin Technologies (PTN) Announces Notification of Patent Allowance on Melanocortin Receptor-Specific Peptides for Sexual Dysfunction
5/2/2013 10:00:15 AM
More...
|
Palatin Technologies (PTN) Announces Notification of Patent Allowance on Melanocortin Receptor-1 Specific Peptides
3/19/2013 10:00:40 AM
More...
|
Palatin Technologies (PTN) to Present at the 25th Annual ROTH Conference
3/15/2013 8:13:01 AM
More...
|
Palatin Technologies (PTN) to Present at the Cowen and Company 33rd Annual Health Care Conference
3/4/2013 6:32:55 AM
More...
|
Palatin Technologies (PTN) Presents Positive Data for Bremelanotide in Female Sexual Dysfunction
3/1/2013 9:54:38 AM
More...
|
Palatin Technologies (PTN) Reports Second Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on February 14, 2013
2/14/2013 7:33:48 AM
More...
|
Palatin Technologies (PTN) to Report Fiscal Year 2013 Second Quarter Results; Teleconference and Webcast to be Held on February 14, 2013
2/8/2013 7:25:18 AM
More...
|
Palatin Technologies (PTN) to Present at 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/8/2013 7:17:45 AM
More...
|
|